Midrodine Recall Paused While FDA Reviews Drug Data
Federal drug safety reviewers are backing off threats to force a recall of midrodine, which is marketed as ProAmantine, indicating that they will give the manufacturers of the low blood pressure…
Federal drug safety reviewers are backing off threats to force a recall of midrodine, which is marketed as ProAmantine, indicating that they will give the manufacturers of the low blood pressure…
The FDA is proposing to remove drug approval for the low blood pressure drug ProAmantine and its generics, which would result in a ProAmantine recall from the market.